The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tertbutylhydroquinone or 3-(3'-tert-butyl-4'- hydroxyphenyl)propylthiosulfonate of sodium

Alexandra B. Shintyapina, Valentin A. Vavilin, Olga G. Safronova, Vyacheslav V. Lyakhovich

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Abstract

    Tert-butylhydroquinone (tBHQ) is a highly effective phenolic antioxidant used in edible oils and fats in foods as well as in medicines and cosmetics. TBHQ has been shown to have both chemoprotective and carcinogenic effects. Furthermore, it has potential anti-inflammatory, antiatherogenic, and neuroprotective activities. TBHQ induces phase II detoxification enzymes via the Keap1/Nrf2/ARE mechanism, which contributes to its chemopreventive functions. Nonetheless, there is growing evidence that biological effects of tBHQ may be mediated by Nrf2-independent mechanisms related to various signaling cascades. Here, we studied changes in gene expression of phase I, II, and III drug metabolizing enzymes/transporters as well as protein levels and activities of cytochromes P450 (CYPs) elicited by tBHQ and its structural homolog TS-13 in the mouse liver. Next, we carried out gene expression analysis to identify signal transduction pathways modulated by the antioxidants. Mice received 100 mg/kg tBHQ or TS-13 per day or only vehicle. The liver was collected at 12 hours and after 7 days of the treatment. Protein and total RNA were extracted. Gene expression was analyzed using Mouse Drug Metabolism and Signal Transduction PathwayFinder RT2Profiler PCR Arrays. A western blot analysis was used to measure protein levels and a fluorometric assay was employed to study activities of CYPs. Genes that were affected more than 1.5-fold by tBHQ or TS-13 treatment compared with vehicle were identified. Analysis of the gene expression data revealed changes in various genes that are important for drug metabolism, cellular defense mechanisms, inflammation, apoptosis, and cell cycle regulation. Novel target genes were identified, including xenobiotic metabolism genes encoding CYPs, phase II/III drug metabolizing enzymes/transporters. For Cyp1a2 and Cyp2b, we observed an increase in protein levels and activities during tBHQ or TS-13 treatment. Changes were found in the gene expression regulated by NFκB, androgen, retinoic acid, PI3K/AKT, Wnt, Hedgehog and other pathways.

    Original languageEnglish
    Article number0176939
    Pages (from-to)e0176939
    Number of pages25
    JournalPLoS ONE
    Volume12
    Issue number5
    DOIs
    Publication statusPublished - 1 May 2017

    Keywords

    • Animals
    • Blotting, Western
    • Cytochrome P-450 Enzyme System/metabolism
    • Hydroquinones/pharmacology
    • Inactivation, Metabolic/drug effects
    • Liver/drug effects
    • Male
    • Mice
    • Mice, Inbred BALB C
    • Microsomes, Liver/drug effects
    • Real-Time Polymerase Chain Reaction
    • Signal Transduction/drug effects
    • Thiosulfonic Acids/pharmacology
    • Transcriptome/drug effects
    • HUMAN NEUROBLASTOMA-CELLS
    • OXIDATIVE STRESS
    • ACTIVATED PROTEIN-KINASE
    • INDUCED APOPTOSIS
    • PHOSPHATIDYLINOSITOL 3-KINASE
    • ANTIOXIDANT-RESPONSIVE ELEMENT
    • CONSTITUTIVE ANDROSTANE RECEPTOR
    • COORDINATE REGULATION
    • INFLAMMATORY RESPONSE
    • NF-KAPPA-B

    Fingerprint

    Dive into the research topics of 'The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tertbutylhydroquinone or 3-(3'-tert-butyl-4'- hydroxyphenyl)propylthiosulfonate of sodium'. Together they form a unique fingerprint.

    Cite this